Based on these studies we postulated that interference with the FGL2-FCγRIIB inhibitory pathway would enhance anti-viral immune innate and adaptive immune responses in the experimental model of acute viral hepatitis caused by LCMV-WE. The gene discussed is FCGR2B; the disease is animal viral hepatitis.